The headline numbers for Figs (FIGS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The consensus price target hints at a 27.1% upside potential for Figs (FIGS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
FIGS eyes 21.9% revenue growth in Q1 2026, driven by strong demand, pricing power and global expansion despite tariff and margin pressures.
SIG's premium mix, pricing power and core brands fuel margin gains, as rising AUR and strong services growth set up fiscal 2027 momentum.
Does Figs (FIGS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Figs (FIGS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is how Figs (FIGS) and Tilly's (TLYS) have performed compared to their sector so far this year.
Figs (FIGS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
FIGS, QTTB and NESR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 19, 2026.
FIGS, QTTB, ORN, FIX and PIPR have been added to the Zacks Rank #1 (Strong Buy) List on March 19, 2026.
After a stunning plunge following its 2021 IPO, medical and lifestyle apparel company FIGS, Inc. (NYSE: FIGS) has roared back to life, trading at a price it hasn't touched in nearly four years. The stock, currently trading above $17, has surged almost 260% over the past year, including a 58% spike in the last month alone.
Here is how Figs (FIGS) and Tapestry (TPR) have performed compared to their sector so far this year.